| 1 |
34136707 | Arginine Vasopressin as an Important Mediator of Fluctuations in the Serum Creatinine Concentration Under Decongestion Treatment in Heart Failure Patients. | 2021 May 18 |
1 |
| 2 |
34785062 | Copeptin as a marker of atherosclerosis and arteriosclerosis. | 2021 Dec |
1 |
| 3 |
32505416 | Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy. | 2020 Aug |
1 |
| 4 |
33581704 | Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents? | 2020 Dec 16 |
1 |
| 5 |
30309264 | Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort. | 2019 Jan |
1 |
| 6 |
31187425 | Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients. | 2019 Sep |
2 |
| 7 |
29079359 | The copeptin response after physical activity is not associated with cardiac biomarkers or asymptomatic coronary artery disease: The North Sea Race Endurance Exercise Study (NEEDED) 2013. | 2018 Feb |
1 |
| 8 |
29527508 | Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease? | 2018 Mar 6 |
1 |
| 9 |
28057871 | Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients. | 2017 Jan 1 |
1 |
| 10 |
27404700 | Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction. | 2016 Oct 15 |
1 |
| 11 |
24251953 | Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension. | 2013 Nov 19 |
1 |
| 12 |
22962322 | The impact of intraoperative vasopressin infusion in complex neonatal cardiac surgery. | 2012 Dec |
1 |
| 13 |
21616953 | Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. | 2011 Jul |
1 |
| 14 |
20606409 | Vasopressin and its immune effects in septic shock. | 2010 |
1 |
| 15 |
21168678 | Copeptin in relation to New York Heart Association class in heart transplant recipients and kidney transplant recipients. | 2010 Dec |
1 |
| 16 |
19572935 | Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. | 2009 Sep |
1 |
| 17 |
17019548 | Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. | 2006 Nov |
1 |
| 18 |
11873030 | Beneficial effects of short-term vasopressin infusion during severe septic shock. | 2002 Mar |
1 |
| 19 |
10728802 | Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. | 2000 |
1 |
| 20 |
8900380 | Role of urinary arginine vasopressin in the sodium excretion in patients with chronic renal failure. | 1996 Nov |
1 |
| 21 |
7537863 | Urinary excretion of aquaporin-2 in patients with diabetes insipidus. | 1995 Jun 8 |
1 |
| 22 |
2136743 | Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects. | 1990 Jan |
1 |
| 23 |
3514728 | Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. | 1986 Apr |
1 |
| 24 |
3714354 | The effect of assisted ventilation on creatinine clearance and hormonal control of electrolyte balance in very low birth weight infants. | 1986 May |
1 |
| 25 |
3740319 | Urinary and metabolic clearances of arginine vasopressin in normal subjects. | 1986 Aug |
1 |
| 26 |
4085913 | Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis. | 1985 Dec |
1 |
| 27 |
4094035 | Role of mesangial proliferation in angiotensin II and antidiuretic hormone induced changes in glomerular filtration rate. | 1985 Nov |
1 |
| 28 |
5101300 | "Essential" hypernatremia due to ineffective osmotic and intact volume regulation of vasopressin secretion. | 1971 Jan |
1 |